Cannabinol and Sleep: Separating Fact from Fiction

In recent years, marketers of cannabis (i.e., marijuana) products have claimed that cannabinol (CBN) has unique sleep-promoting effects. Despite a plausible mechanism, it is possible that such claims are merely rooted in cannabis lore. The aim of this narrative review was to answer the question: "Is there sufficient clinical evidence to support claims that CBN has sleep-promoting effects?" A systematic search of PubMed/MEDLINE was performed to evaluate the published evidence. The abstracts of 99 human studies were screened for relevance by the author and reviewed for compliance with the inclusion criteria. The characteristics and principal findings were extracted from eight full-text articles that met inclusion criteria for detailed review. Pre-clinical and clinical research investigating the effects of CBN is dated and limited, with the preponderance of human studies occurring in the 1970-1980s with small sample sizes lacking diversity in sociodemographic characteristics. Studies specifically assessing subjective effects associated with sleep, such as sedation or fatigue, are rare. Most importantly, published clinical trials investigating associations between CBN and validated sleep questionnaires and/or formal polysomnography were not identified in this review. In addition, evidence demonstrating that CBN itself elicits cannabis-like effects in humans is mixed, with the majority of available evidence demonstrating a lack of such an effect. Consequently, there is insufficient published evidence to support sleep-related claims. Randomized controlled trials are needed to substantiate claims made by manufacturers of cannabis products containing CBN. These studies should specifically evaluate its effects on sleep through polysomnography, or at minimum, through validated sleep questionnaires, and use dosages significantly higher than those found in currently available cannabis products marketed for sleep (typically ≤5 mg). Individuals seeking cannabis-derived sleep aids should be skeptical of manufacturers' claims of sleep-promoting effects.

Keywords: CBN; THC; cannabinoids; cannabis; marijuana; sleep.

Conflict of interest statement

J.C. is the medical director at the Center for Medical Cannabis Education, a for-profit clinical and consulting entity.

Similar articles

Jaidee W, Siridechakorn I, Nessopa S, Wisuitiprot V, Chaiwangrach N, Ingkaninan K, Waranuch N. Jaidee W, et al. Cannabis Cannabinoid Res. 2022 Aug;7(4):537-547. doi: 10.1089/can.2021.0004. Epub 2021 Jun 4. Cannabis Cannabinoid Res. 2022. PMID: 34096805 Free PMC article.

Miller OS, Elder EJ Jr, Jones KJ, Gidal BE. Miller OS, et al. Epilepsy Behav. 2022 Feb;127:108514. doi: 10.1016/j.yebeh.2021.108514. Epub 2022 Jan 5. Epilepsy Behav. 2022. PMID: 34998268

Fernández N, Cappello MG, Quiroga PN. Fernández N, et al. Forensic Sci Int. 2023 Aug;349:111762. doi: 10.1016/j.forsciint.2023.111762. Epub 2023 Jun 22. Forensic Sci Int. 2023. PMID: 37392612

Lutge EE, Gray A, Siegfried N. Lutge EE, et al. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD005175. doi: 10.1002/14651858.CD005175.pub3. Cochrane Database Syst Rev. 2013. PMID: 23633327 Review.

Nguyen GN, Jordan EN, Kayser O. Nguyen GN, et al. J Nat Prod. 2022 Jun 24;85(6):1555-1568. doi: 10.1021/acs.jnatprod.2c00155. Epub 2022 Jun 1. J Nat Prod. 2022. PMID: 35648593 Review.

Cited by

Sip S, Stasiłowicz-Krzemień A, Sip A, Szulc P, Neumann M, Kryszak A, Cielecka-Piontek J. Sip S, et al. Molecules. 2024 Jul 29;29(15):3574. doi: 10.3390/molecules29153574. Molecules. 2024. PMID: 39124978 Free PMC article.

Blebea NM, Pricopie AI, Vlad RA, Hancu G. Blebea NM, et al. Int J Mol Sci. 2024 Apr 10;25(8):4204. doi: 10.3390/ijms25084204. Int J Mol Sci. 2024. PMID: 38673788 Free PMC article. Review.

Lewis M, Baroutian S, Hanning SM. Lewis M, et al. Curr Pain Headache Rep. 2024 Mar;28(3):109-118. doi: 10.1007/s11916-023-01196-1. Epub 2023 Dec 14. Curr Pain Headache Rep. 2024. PMID: 38095748 Review.

Wilson G, Yang L, Su X, Ding S, Li L, Yang Y, Wang X, Wang W, Sa Y, Zhang Y, Chen J, Ma X. Wilson G, et al. Pharmacol Rep. 2023 Dec;75(6):1410-1444. doi: 10.1007/s43440-023-00544-7. Epub 2023 Oct 31. Pharmacol Rep. 2023. PMID: 37906390 Review.

Kolobaric A, Hewlings SJ, Bryant C, Colwell CS, R D'Adamo C, Rosner B, Chen J, Pauli EK. Kolobaric A, et al. Nutrients. 2023 Aug 30;15(17):3788. doi: 10.3390/nu15173788. Nutrients. 2023. PMID: 37686820 Free PMC article. Clinical Trial.

References

    1. Garber-Paul Elisabeth. Why CBN iss a psychoactive sleep aid alternative. Rolling Stone. 2020. Updated July 21, 2020. https://www.rollingstone.com/culture/culture-news/cbn-sleep-aid-psychoac. Accessed July 21, 2020.
    1. Is CBN Oil Legal? 2021. https://cbnoilforsleep.com/is-cbn-oil-legal Accessed April 12, 2020.
    1. Peter Grinspoon MD. Beyond CBD: here come the other cannabinoids, but where's the evidence? Harvard Health Blog. 2021.
    1. Section 802—Title 21 United States Code (USC) Controlled Substances Act. 2018. https://www.deadiversion.usdoj.gov/21cfr/21usc/802.htm Accessed April 12, 2020.
    1. McConnell Mitch. Text—S.2667—115th Congress (2017–2018): Hemp Farming Act of 2018. 2018.